Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases

被引:0
|
作者
Leandro Marcelo Martinez
Valeria Beatriz Fernández Vallone
Vivian Labovsky
Hosoon Choi
Erica Leonor Hofer
Leonardo Feldman
Raúl Horacio Bordenave
Emilio Batagelj
Federico Dimase
Ana Rodriguez Villafañe
Norma Alejandra Chasseing
机构
[1] National Council of Scientific and Technical Research (CONICET),Immunohematology Laboratory, Experimental Biology and Medicine Institute (IBYME)
[2] Institute for Regenerative Medicine at Scott & White,Texas A&M Health Science Center, College of Medicine
[3] Favaloro Fundation,Department of Bone Marrow Transplantation
[4] Iriarte Hospital,Department of Oncology
[5] Central Militar Hospital,Department of Oncology
[6] Central Militar Hospital,Department of Hemotherapy
[7] Central Militar Hospital,Department of Diagnosis and Treatment
来源
关键词
Breast cancer; Bone marrow; Pre-metastatic niche; Mesenchymal stem cells; Bone metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
Bone metastasis is an incurable complication of breast cancer affecting 70–80 % of advanced patients. It is a multistep process that includes tumour cell mobilisation, intravasation, survival in the circulation, extravasation, migration and proliferation in the bone marrow/bone. Although novel findings demonstrate the bone marrow microenvironment significance in bone metastatic progression, a majority of studies have focused on end-stage disease and little is known about how the pre-metastatic niche arises in the bone marrow/bone tissues. We demonstrated a significant increase in patients’ peripheral blood plasma ability to induce transendothelial migration of MCF-7 cells compared with healthy volunteers. Moreover, high RANKL, MIF and OPG levels in patients’ peripheral blood could play a role in the intravasation, angiogenesis, survival and epithelial–mesenchymal transition of circulating tumour cells. Also, we observed a significant increase in patients’ bone marrow plasma capacity to induce transendothelial migration of MDA-MB231 and MCF-7 cells compared with healthy volunteers. Furthermore, patients’ bone marrow mesenchymal stem cells could control the recruitment of tumour cells, modifying the MCF-7 and MDA-MB231 cell migration. In addition, we found a significantly higher MDA-MB231 cell proliferation when we used patients’ bone marrow plasma compared with healthy volunteers. Interestingly, PDGF-AB, ICAM-1 and VCAM-1 levels in patients’ bone marrow were significantly higher than the values of healthy volunteers, suggesting that they could be involved in the cancer cell extravasation, bone resorption and cancer cell proliferation. We believe that these results can reveal new information about what alterations happen in the bone marrow of advanced breast cancer patients before bone colonisation, changes that create optimal soil for the metastatic cascade progression.
引用
收藏
页码:213 / 232
页数:19
相关论文
共 50 条
  • [31] Radiotherapy for bone metastases of breast cancer: radiation doses and bone marrow recovery
    Kanaev, S
    Novikov, S
    Jukova, L
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S70 - S70
  • [32] Bone Marrow Involvement Is Associated with High Numbers of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients.
    Grisanti, S.
    Consoli, F.
    Almici, C.
    Bertagna, F.
    Verardi, R.
    Ungari, M.
    Amoroso, V.
    Pedersini, R.
    Vassalli, L.
    Montani, E.
    Simoncini, E. L.
    CANCER RESEARCH, 2011, 71
  • [33] Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases
    Todenhoefer, Tilman
    Hennenlotter, Joerg
    Schmiedel, Benjamin Joachim
    Hohneder, Andrea
    Grimm, Sabrina
    Kuehs, Ursula
    Salih, Helmut Rainer
    Buehring, Hans-Joerg
    Fehm, Tanja
    Gakis, Georgios
    Blumenstock, Gunnar
    Aufderklamm, Stefan
    Schilling, David
    Stenzl, Arnulf
    Schwentner, Christian
    PROSTATE, 2013, 73 (02): : 162 - 168
  • [34] HER-2/NEU mRNA in peripheral blood & bone marrow in female breast cancer patients
    El Hamid, A. Abd
    Elkamash, M.
    Eskander, G.
    Hassan, A.
    aziz, F. Abdel
    Attia, F.
    Hassan, S.
    Hassan, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 537 - 538
  • [35] Denosumab for the treatment of bone metastases in advanced breast cancer
    Casas, Ana
    Llombart, Antonio
    Martin, Miguel
    BREAST, 2013, 22 (05): : 585 - 592
  • [36] Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients
    Borzone, Francisco Raul
    Giorello, Maria Belen
    Martinez, Leandro Marcelo
    Sanmartin, Maria Cecilia
    Feldman, Leonardo
    Dimase, Federico
    Batagelj, Emilio
    Yannarelli, Gustavo
    Chasseing, Norma Alejandra
    ONCOLOGY RESEARCH, 2023, 31 (03) : 361 - 374
  • [37] CD 146 positive bone marrow mesenchymal stem cells in advanced stages of untreated lung and breast cancer patients
    Fernandez Vallone, Valeria Beatriz
    Choi, Hooson
    Labovsky, Vivian
    Martinez, Leandro
    Bordenave, Horacio
    Feldman, Leonardo
    Alejandra Chasseing, Norma
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 198 - 199
  • [38] BONE METASTASES AND BONE PAIN IN BREAST-CANCER - ARE THEY CLOSELY ASSOCIATED
    FRONT, D
    SCHNECK, SO
    FRANKEL, A
    ROBINSON, E
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 242 (16): : 1747 - 1748
  • [39] Bone marrow microenvironment of advanced breast cancer patients without bone metastasis favors the cancer cell colonization
    Martinez, Leandro M.
    Fernandez Vallone, Valerie B.
    Lebovsky, Vivian
    Chol, Hosoon
    Feldman, Leonardo
    Bordenave, Raul H.
    Batageij, Emilio
    Dimase, Federico
    Rodriguez Villafafie, Ana
    Chasseing, Norma A.
    CANCER RESEARCH, 2013, 73
  • [40] Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients.
    de Cavanagh, EM
    Honegger, AE
    Hofer, E
    Bordenave, RH
    Bullorsky, EO
    Fraga, C
    Chasseing, NA
    BLOOD, 2000, 96 (11) : 149B - 149B